Can lisinopril cause thinning of the skin and increased bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lisinopril Does NOT Cause "Thin Skin" or Easier Bleeding

Lisinopril is not associated with skin thinning or increased bleeding risk as a recognized adverse effect. The FDA-approved drug labeling for lisinopril does not list thin skin or bleeding as adverse reactions 1. The primary dermatologic concerns with lisinopril are angioedema, rash, and rarely, autoimmune-type skin conditions—not skin fragility or bleeding.

What Lisinopril Actually Causes

Documented Skin Reactions

The FDA label and clinical evidence identify these actual dermatologic adverse effects 1:

  • Angioedema (potentially life-threatening swelling of face, lips, tongue, throat)
  • Rash and urticaria (hives)
  • Photosensitivity (increased sun sensitivity)
  • Pruritus (itching)
  • Rare autoimmune conditions: bullous pemphigoid 2, cutaneous vasculitis 3, psoriasis flares 4
  • Alopecia (hair loss) 5

Bleeding Risk Profile

Lisinopril does not increase bleeding risk. In fact, comparative data from the ALLHAT trial showed that lisinopril was associated with a higher risk of gastrointestinal bleeding compared to amlodipine (HR 1.27), but this was likely related to other factors rather than a direct bleeding mechanism 6. ACE inhibitors do not affect platelet function or coagulation pathways.

Common Pitfalls to Avoid

Do not confuse lisinopril with antiplatelet agents or anticoagulants. Patients often use the term "blood thinners" generically, but lisinopril:

  • Does NOT thin the blood
  • Does NOT affect clotting
  • Does NOT cause easy bruising or bleeding
  • Does NOT cause skin fragility

If a patient reports "thin skin" and bleeding while on lisinopril, investigate alternative causes:

  • Chronic corticosteroid use (the actual cause of skin thinning and easy bruising)
  • Antiplatelet agents (aspirin, clopidogrel) 7, 8, 9, 7
  • Anticoagulants (warfarin, DOACs)
  • Age-related skin changes (senile purpura)
  • Vitamin C deficiency
  • Connective tissue disorders

When to Suspect Lisinopril-Related Skin Problems

Monitor for these actual lisinopril-associated conditions:

  1. Angioedema - Discontinue immediately if tongue, lip, or throat swelling occurs 1
  2. New rash within weeks to months of starting therapy 5
  3. Blistering eruptions - Consider drug-induced bullous pemphigoid if bullae develop 2
  4. Purpuric rash - May indicate cutaneous vasculitis (rare) 3

Clinical Recommendation

If your patient attributes "thin skin" and bleeding to lisinopril, reassure them this is not a known effect of the medication. Conduct a thorough medication review for actual culprits (corticosteroids, antiplatelet/anticoagulant drugs) and evaluate for age-related or nutritional causes of skin fragility. Continue lisinopril if indicated for cardiovascular or renal protection 10, 11, 12, as the mortality and morbidity benefits are substantial and should not be abandoned based on misattributed side effects.

References

Research

Cutaneous vasculitis secondary to ramipril.

Journal of drugs in dermatology : JDD, 2004

Guideline

kidney dysfunction in heart failure: core curriculum 2025.

American Journal of Kidney Diseases, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.